Parotid gland incidentalomas: A single-institution experience.
暂无分享,去创建一个
[1] Z. Metwalli,et al. Clinicopathological features of incidental parotid lesions , 2021, Head & Face Medicine.
[2] C. Beadsmoore,et al. Parotid incidentalomas on positron emission tomography: what is their clinical significance? , 2019, Nuclear medicine communications.
[3] O. Guntinas-Lichius,et al. Contemporary Management of Benign and Malignant Parotid Tumors , 2018, Front. Surg..
[4] T. Kennedy,et al. Incidental Findings on FDG PET/CT in Head and Neck Cancer , 2018, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[5] P. Hudgins,et al. Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors? , 2016, AJR. American journal of roentgenology.
[6] A. Gotra,et al. Clinical significance of parotid gland incidentalomas on (18)F-FDG PET/CT. , 2015, Clinical imaging.
[7] P. Harari,et al. Incidental Parotid Neoplasms , 2015, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[8] M. Quer,et al. Parotid Incidentaloma Identified by Positron Emission/Computed Tomography: When to Consider Diagnoses Other than Warthin Tumor , 2014, International Archives of Otorhinolaryngology.
[9] C. Zuo,et al. (18)F-FDG PET/CT of adrenal lesions. , 2014, AJR. American journal of roentgenology.
[10] Y. Cho,et al. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy , 2014, European Radiology.
[11] A. Christe,et al. MR Imaging of Parotid Tumors: Typical Lesion Characteristics in MR Imaging Improve Discrimination between Benign and Malignant Disease , 2011, American Journal of Neuroradiology.
[12] S. Alibek,et al. Diagnosing common parotid tumours with magnetic resonance imaging including diffusion-weighted imaging vs fine-needle aspiration cytology: a comparative study. , 2010, Dento maxillo facial radiology.
[13] Y. Guan,et al. Efficacy of conventional whole-body 18F-FDG PET/CT in the incidental findings of parotid masses , 2010, Annals of nuclear medicine.
[14] J. Beatty,et al. Incidental PET/CT findings in the cancer patient: how should they be managed? , 2009, Surgery.
[15] B. Rho,et al. Parotid incidentaloma identified by combined 18F-fluorodeoxyglucose whole-body positron emission tomography and computed tomography: findings at grayscale and power Doppler ultrasonography and ultrasound-guided fine-needle aspiration biopsy or core-needle biopsy , 2009, European Radiology.
[16] H. Thoeny. Imaging of salivary gland tumours , 2007, Cancer imaging : the official publication of the International Cancer Imaging Society.
[17] Y. Okamoto,et al. Diagnostic Value of FDG PET and Salivary Gland Scintigraphy for Parotid Tumors , 2005, Clinical nuclear medicine.
[18] S. Yasuda,et al. Four cases of Warthin’s tumor of the parotid gland detected with FDG PET , 1998, Annals of nuclear medicine.
[19] Vories Aa,et al. Warthin's tumor and cigarette smoking. , 1997 .
[20] P. Cole,et al. Cigarette smoking and Warthin's tumor. , 1996, American journal of epidemiology.
[21] C. Kotwall. Smoking as an etiologic factor in the development of Warthin's tumor of the parotid gland. , 1992, American journal of surgery.
[22] G. Seifert,et al. Metastatic tumors to the parotid and submandibular glands--analysis and differential diagnosis of 108 cases. , 1986, Pathology, research and practice.